Zevra Therapeutics Inc (ZVRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.01 unch (unch) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.01 unch (unch) 16:22 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 33,785 | 43,049 | 65,466 | 112,346 | 4,322 |
Marketable Securities | 35,711 | 24,688 | 17,381 | N/A | N/A |
Receivables | 10,509 | 17,377 | 8,299 | 1,528 | 2,579 |
Inventories | 1,970 | N/A | N/A | N/A | N/A |
TOTAL | $86,027 | $86,938 | $92,834 | $115,056 | $8,382 |
Non-Current Assets | |||||
PPE Net | 356 | 736 | 794 | 884 | 1,039 |
Investments And Advances | 6,010 | 0 | 20,000 | 15,422 | 0 |
Intangibles | 73,694 | 73,928 | 0 | 0 | 0 |
Other Non-Current Assets | 12,040 | 10,725 | 1,712 | 1,579 | 1,788 |
TOTAL | $92,100 | $85,389 | $22,506 | $17,885 | $2,827 |
Total Assets | $178,127 | $172,327 | $115,340 | $132,941 | $11,209 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 37,700 | N/A | N/A | 390 |
Accounts payable and accrued liabilities | 25,456 | 28,403 | 6,169 | 3,038 | 6,647 |
Other current liabilities | 8,189 | 7,074 | 5,374 | 836 | 172 |
TOTAL | $34,065 | $73,720 | $12,023 | $4,230 | $7,536 |
Non-Current Liabilities | |||||
Long Term Debt | 59,504 | 5,066 | 12,800 | N/A | 391 |
aiOther Non-Current Liabilities | 44,892 | 31,677 | 15,397 | 1,593 | 69,694 |
TOTAL | $104,396 | $36,743 | $28,197 | $1,593 | $70,085 |
Total Liabilities | $138,461 | $110,463 | $40,220 | $5,823 | $77,621 |
Shareholders' Equity | |||||
Shares Outstanding, K | 54,116 | 43,426 | 34,540 | 34,423 | 28,376 |
Common Shares | 5 | 4 | 3 | 4 | 0 |
Retained earnings | -505,289 | -399,778 | -353,729 | -267,029 | -258,474 |
Other shareholders' equity | 648 | -26 | 577 | 186 | 0 |
TOTAL | $39,666 | $61,864 | $75,120 | $127,118 | $-66,412 |
Total Liabilities And Equity | $178,127 | $172,327 | $115,340 | $132,941 | $11,209 |